Congratulations On Kintai Being Recognized As A National High-tech Enterprise

Good news

Warm congratulations 

Our company has been recognized as a national high-tech enterprise

In accordance with the relevant provisions of the Administrative Measures for the Recognition of High tech Enterprises (GKFH [2016] No. 32) and the Guidelines for the Administration of the Recognition of High tech Enterprises (GKFH [2016] No. 195), the list of high-tech enterprises recognized in Shaanxi Province in 2022 was published, and Xi'an Kintai Biotech Inc. was listed as one of the "National High tech Enterprises"

This certificate is not only an honor, but also a responsibility. The acquisition of this certificate has brought new opportunities for our company to build an innovative enterprise, making it possible for the company to win more technical and policy support from the state in the process of innovation and development; It also provides a fundamental guarantee for the company to strengthen technological innovation and develop new products with high-tech content in the future. The recognition of "National High tech Enterprise" is a full affirmation of Jintai's biotechnology innovation ability, core independent intellectual property rights, scientific and technological achievements transformation ability and high growth of the enterprise.

The certification of high-tech enterprises is the recognition of enterprises that continue to carry out research and development and technological achievements transformation, form core independent intellectual property rights of enterprises, and carry out production and operation activities on this basis in the high-tech field supported by the state, aiming to cultivate and create new technologies and new business forms, and promote economic upgrading and development. The identification of national high-tech enterprises has strict requirements for enterprises, which are guided and managed by the Ministry of Science and Technology, the Ministry of Finance and the State Administration of Taxation.

Xi'an Kintai Biotech Inc. focuses on the R&D, production and sales of plant extracts and pharmaceutical intermediates.

The company has an independent research and development laboratory, which has innovatively solved and optimized a number of key technologies in the extraction, separation, filtration, detection and packaging of high content and high purity standard plant extracts and pharmaceutical intermediates, and has obtained several products and related patents such as lappaconitine hydrobromide, mangiferin, dihydromyricetin, polydatin, rosmarinic acid, betulin. The company constantly blazes new trails, vigorously develops new technologies, develops new products, actively introduces outstanding talents in the biomedical industry, and builds its core competitiveness with team based enterprise advantages, standardized project management, innovative biotechnology, and integrated resource support, so as to provide domestic and foreign customers with personalized natural plant products and whole process services that vary according to their needs.  

The passing of the national high-tech enterprise certification is not only the recognition of Jintai's scientific research ability and overall technical level by the state and governments at all levels, but also a spur and incentive for Jintai Bio. In the future, Jintai Bio will forge ahead, focus on increasing scientific research investment and training talent team to build a new technological innovation system. While giving full play to the innovation advantages of high-tech enterprises, we should enhance the core competitiveness of enterprises, enrich the stamina of enterprise innovation and development, and provide strong technical support for the sustainable development of enterprises.